Direct Access

to personalized medicine


Molecular diagnostics beyond simplicity


in-house cartridge

manufacturing line

BRAF Mutation Test

Simple, rapid, highly sensitive

diagnostics at hand.

A passionate team

driven to make a change


Biocartis aims to provide direct access to personalized medicine for patients worldwide by developing fully integrated and broadly applicable molecular diagnostics. Our platforms can be used in a wide variety of healthcare settings to enable rapid and high-quality care close to patients.


Idylla, Biocartis’ fully automated, real-time PCR based molecular system, is designed to offer physicians fast access to clinical molecular diagnostic information, anywhere and anytime. Idylla detects and quantifies multiple DNA or RNA-based biomarkers in a wide variety of patient sample types. Idylla™ and the system’s first assay, the Idylla™ BRAF Mutation Test, have obtained CE-IVD marking.

Personalized Medicine

Personalized medicine allows making treatments more targeted to individual patient characteristics using molecular analysis. In order to make personalized medicine a sustainable reality, doctors need accurate, accessible, cost-effective molecular tests that provide correct molecular information within a reasonable time frame.